Boston Scientific Corporation (NYSE: BSX) today, September 28, announced it has initiated a controlled launch of its ACURATE neo2™ Aortic...

Boston Scientific (NYSE:BSX) shares fell over 3% following the release of SCOPE II trial data at TCT Connect 2020. The data showed that...

MARLBOROUGH, Mass., Dec. 1, 2020 /PRNewswire/ -- Boston Scientific Corporation announced that it has entered into a definitive agreement...